N-terminal GST-tagged-Mcl-1 protein from Mcl-1 (E171-G327), N-terminal GST-tagged Bcl-xL protein from Bcl-xL (1-209), N-Terminal 6His-tagged Bfl-1 protein from Bfl-1 (M1-K151), N-Terminal 6His-tagged Bcl-w protein from Bcl-w (M1-R171), and C-Terminal 6His-tagged Bcl-2 protein from Bcl-2 (M1-F212) were expressed as a tagged fusion protein in E. coli and subsequently purified via Glutathione Sepharose-affinity or Ni-NTA resin purification, and size-exclusion chromatography.
For TR-FRET, tagged fusion proteins were incubated with a Europium-labeled antibody and a HyLite Fluor 647-labeled peptide, or a biotin-labeled peptide with a streptavidin-labeled ulight fluorophore allowing the assembly of donor and acceptor dye pairs for use in protein-binding assays.
The assay was performed in 384-well plates and IC50 values were assessed from a 10-point, half-log10 dilution starting at 100 or 10 µM of compound. The reaction final concentrations for Mcl-1 were 1.5 nM GST-Mcl-1, 0.5 nM LanthaScreen Eu tagged GST antibody (LifeTechnologies cat#PV5594), and 4 nM HyLite Fluor 647-labeled Bim peptide C (Hilyte647 C2 Maleimide)-WIAQELRRIGDEFN; for Bcl-xl were 2 nM GST-Bcl-xl, 2 nM LanthaScreen Eu-tagged GST antibody, and 10 nM HyLite Fluor 647-labeled BAK peptide C(Hilyte647 C2 Maleimide)-GGGQVGRQLAIIGDDINR; for Bfl-1 were 4 nM His-Bfl-1, 0.5 nM LanthaScreen Eu-tagged HIS antibody (PerkinElmer cat#AD0205), and 10 nM HyLite Fluor 647-labeled BIM peptide C(Hilyte647-C2-Maleimide)-WIAQELRRIGDEFN; for Bcl-2 and Bcl-w: 2 nM His-Bcl-2, or 2 nM His-Bcl-w, with 0.5 nM LanthaScreen Eu-tagged HIS antibody, 10 nM biotin-labeled Bim peptide (Biotin-lc-GGMRPEIWIANELRRIGDEFNA), and 2.4 nM a streptavidin labeled ULight Fluorophore (PerkinElmer cat#TRF0102-D). Reactions were incubated at 24 °C for 120–180 min before reading on a Tecan (InfiniteM1000 spectrofluorometer) with excitation at 340 nm and emission at 612 and 665 nm. Ratio of fluorescent emission intensity at 665–620 nm was calculated for each reaction (equation 1). Percent inhibition was calculated based upon min (control compound) vs. max (DMSO) according to Eq. (2) and the IC50 was derived the smart fit curve (Genedata screener) of % inhibition vs. concentration. Ki values were calculated from Eq. (3) and the parameters in Table 2.
TR-FRET assay-binding parameters of Bim or Bak peptides to Bcl-2 pro-survival proteins used in Ki calculations
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.